Funder: Kenneth Rainin Foundation
Due Dates (Anticipated): February 2027 (Invited full proposals) | September 2027 (Letters of Inquiry)
Funding Amounts: Up to $150,000 USD for individual projects or $300,000 USD for collaborative projects over 12 months; up to two additional years based on progress
Summary: Supports innovative basic, translational and clinical research worldwide to advance understanding, prediction, diagnosis, treatment and prevention of Inflammatory Bowel Disease.
Key Information: Each application must have one Principal Investigator; postdoctoral researchers cannot apply as PI.
Description
The Kenneth Rainin Foundation’s Innovator Awards provide early support for new ideas that could transform understanding of Inflammatory Bowel Disease (IBD). The program funds individual and collaborative projects, enabling researchers worldwide to test ideas, gather and share data, and pursue discoveries that improve prediction, diagnosis, treatment and prevention. It combines the Foundation’s former Innovator and Synergy Awards programs.
The Foundation encourages collaboration between scientists and clinicians across immunology, microbiology, gastroenterology, molecular biology, computational biology and other disciplines. It particularly encourages high-impact basic and translational research using artificial intelligence, machine learning, big data analytics and diverse model systems to investigate IBD mechanisms and accelerate therapeutic discovery. Clinical science is also eligible.
